Your search returned 3 results.

Results
	1.	Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients. [electronic resource] by Pirags, V Lebovitz, H Fouqueray, P Producer: 20121030 In: Diabetes, obesity & metabolism vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetes. [electronic resource] by Pacini, G Mari, A Fouqueray, P Bolze, S Roden, M Producer: 20160129 In: Diabetes, obesity & metabolism vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Imeglimin prevents human endothelial cell death by inhibiting mitochondrial permeability transition without inhibiting mitochondrial respiration. [electronic resource] by Detaille, D Vial, G Borel, A-L Cottet-Rouselle, C Hallakou-Bozec, S Bolze, S Fouqueray, P Fontaine, E Producer: 20160823 In: Cell death discovery vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search